These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
220 related articles for article (PubMed ID: 11763492)
41. Radiation-associated sarcoma after recurrent colorectal primary tumor: A complex surgical case. Stephen AH; Fallon EA; Kalife E; Wanebo H J Surg Oncol; 2015 Nov; 112(6):658-61. PubMed ID: 26430853 [TBL] [Abstract][Full Text] [Related]
42. High dose rate and external beam radiotherapy in locally advanced prostate cancer. Viani GA; Pellizzon AC; Guimarães FS; Jacinto AA; dos Santos Novaes PE; Salvajoli JV Am J Clin Oncol; 2009 Apr; 32(2):187-90. PubMed ID: 19307949 [TBL] [Abstract][Full Text] [Related]
43. Prostate brachytherapy seed migration to the right ventricle found at autopsy following acute cardiac dysrhythmia. Davis BJ; Pfeifer EA; Wilson TM; King BF; Eshleman JS; Pisansky TM J Urol; 2000 Nov; 164(5):1661. PubMed ID: 11025737 [No Abstract] [Full Text] [Related]
44. Postradiation sarcomas: 20 cases and a literature review. Murray EM; Werner D; Greeff EA; Taylor DA Int J Radiat Oncol Biol Phys; 1999 Nov; 45(4):951-61. PubMed ID: 10571202 [TBL] [Abstract][Full Text] [Related]
45. Rectal complications after prostate brachytherapy. Shah SA; Cima RR; Benoit E; Breen EL; Bleday R Dis Colon Rectum; 2004 Sep; 47(9):1487-92. PubMed ID: 15486745 [TBL] [Abstract][Full Text] [Related]
46. Is there a role for pelvic irradiation in localized prostate adenocarcinoma? Preliminary results of GETUG-01. Pommier P; Chabaud S; Lagrange JL; Richaud P; Lesaunier F; Le Prise E; Wagner JP; Hay MH; Beckendorf V; Suchaud JP; Pabot du Chatelard PM; Bernier V; Voirin N; Perol D; Carrie C J Clin Oncol; 2007 Dec; 25(34):5366-73. PubMed ID: 18048817 [TBL] [Abstract][Full Text] [Related]
47. Prophylactic tamsulosin (Flomax) in patients undergoing prostate 125I brachytherapy for prostate carcinoma: final report of a double-blind placebo-controlled randomized study. Elshaikh MA; Ulchaker JC; Reddy CA; Angermeier KW; Klein EA; Chehade N; Altman A; Ciezki JP Int J Radiat Oncol Biol Phys; 2005 May; 62(1):164-9. PubMed ID: 15850917 [TBL] [Abstract][Full Text] [Related]
48. Brachytherapy for prostate cancer: is the pretreatment prostate volume important? Meyer JP; Bell CR; Elwell C; Kunkler RB BJU Int; 2008 Dec; 102(11):1585-8. PubMed ID: 18990138 [TBL] [Abstract][Full Text] [Related]
49. Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity. Akimoto T; Ito K; Saitoh J; Noda SE; Harashima K; Sakurai H; Nakayama Y; Yamamoto T; Suzuki K; Nakano T; Niibe H Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):463-71. PubMed ID: 16168838 [TBL] [Abstract][Full Text] [Related]
50. Long-term outcomes in younger men following permanent prostate brachytherapy. Shapiro EY; Rais-Bahrami S; Morgenstern C; Napolitano B; Richstone L; Potters L J Urol; 2009 Apr; 181(4):1665-71; discussion 1671. PubMed ID: 19233394 [TBL] [Abstract][Full Text] [Related]
51. Correlation between dosimetric parameters and late rectal and urinary toxicities in patients treated with high-dose-rate brachytherapy used as monotherapy for prostate cancer. Konishi K; Yoshioka Y; Isohashi F; Sumida I; Kawaguchi Y; Kotsuma T; Adachi K; Morimoto M; Fukuda S; Inoue T Int J Radiat Oncol Biol Phys; 2009 Nov; 75(4):1003-7. PubMed ID: 19345517 [TBL] [Abstract][Full Text] [Related]
52. Patterns of local failure following prostate brachytherapy. Stone NN; Stock RG; White I; Unger P J Urol; 2007 May; 177(5):1759-63; duscussion 1763-4. PubMed ID: 17437808 [TBL] [Abstract][Full Text] [Related]
53. Prostatic acid phosphatase adversely affects cause-specific survival in patients with intermediate to high-risk prostate cancer treated with brachytherapy. Fang LC; Dattoli M; Taira A; True L; Sorace R; Wallner K Urology; 2008 Jan; 71(1):146-50. PubMed ID: 18242384 [TBL] [Abstract][Full Text] [Related]
54. High dose rate brachytherapy as a boost for the treatment of localized prostate cancer. Phan TP; Syed AM; Puthawala A; Sharma A; Khan F J Urol; 2007 Jan; 177(1):123-7; discussion 127. PubMed ID: 17162020 [TBL] [Abstract][Full Text] [Related]
55. Postradiation sarcoma after radiotherapy for nasopharyngeal carcinoma. Chan JY; Wong ST; Lau GI; Wei WI Laryngoscope; 2012 Dec; 122(12):2695-9. PubMed ID: 23070724 [TBL] [Abstract][Full Text] [Related]
56. Carcinoma of the prostate in irradiated parabiotic rats. Brown CE; Warren S Cancer Res; 1978 Jan; 38(1):159-62. PubMed ID: 618574 [TBL] [Abstract][Full Text] [Related]
57. [Mucinous adenocarcinoma of the prostate. Report of 3 cases and review of the literature]. Rodríguez Martínez JJ; Madrigal Rubiales B; Pérez García FJ; Rábade Rey CJ; Fernández Gómez JM; San Martín Blanco A; Escaf Barmadah S Arch Esp Urol; 1997 Nov; 50(9):952-8. PubMed ID: 9527825 [TBL] [Abstract][Full Text] [Related]
58. Osteogenic differentiation associated with x-ray therapy for adenocarcinoma of the prostate gland. Locke JR; Soloway MS; Evans J; Murphy WM Am J Clin Pathol; 1986 Mar; 85(3):375-8. PubMed ID: 3463192 [TBL] [Abstract][Full Text] [Related]
59. Radiation therapy for localized or locally advanced prostate adenocarcinoma and myeloma incidence in a population-based cohort. Ojha RP; Felini MJ; Singh KP; Faramawi MF; Thertulien R BJU Int; 2011 Mar; 107(5):693-7. PubMed ID: 21210963 [No Abstract] [Full Text] [Related]
60. Radiation-induced second malignancies. Mahmood S; Vu K; Tai P; Joseph K; Koul R; Dubey A; Yu E Anticancer Res; 2015 Apr; 35(4):2431-4. PubMed ID: 25862910 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]